YS, L., H, A., S, H., & CY, P. Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Response to Letter]. Dove Medical Press.
Chicago Style (17th ed.) CitationYS, Lyu, Ahn H, Hong S, and Park CY. Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Response to Letter]. Dove Medical Press.
MLA (9th ed.) CitationYS, Lyu, et al. Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Response to Letter]. Dove Medical Press.
Warning: These citations may not always be 100% accurate.